Can last week’s winners Randgold Resources Limited (+8%), Vedanta Resources plc (+8%) and Premier Oil plc (+9%) keep shining?

Royston Wild considers whether recent risers Randgold Resources Limited (LON: RRS), Vedanta Resources plc (LON: VED) and Premier Oil plc (LON: PMO) can continue their heady ascent.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Today I’m running the rule over three recent Footsie risers.

All that glisters…

Precious metals play Randgold Resources (LSE: RRS) enjoyed a stellar rise last week thanks to further gold price strength.

And the digger has maintained this solid momentum in Monday trade, a breakthrough £67.10 per share taking it to within a whisker of fresh three-and-a-half-year highs.

Bullion prices are gaining as Brexit-related risk aversion — combined with enduring fears over Chinese and US economic growth — has seen investors piling into safe-haven assets. On top of this, gold is also benefitting from fresh weakness in the dollar.

But while these factors could continue to support metal prices, I believe gold’s medium-term outlook remains on unsteady ground. The likelihood of Federal Reserve rate hikes in the coming months could easily send the precious metal toppling again. And of course demand from key physical markets China and India continues to sink.

I reckon a prospective P/E rating of 34.2 times makes Randgold Resources far too expensive given gold’s muddy price picture.

Zinc zinger

Zinc giant Vedanta Resources (LSE: VED) also received a welcome bump during last Monday-Friday.

The company has been buoyed by zinc prices surging to their highest since summer 2015, while a bounce in other key commodities like oil and aluminium has also helped Vedanta’s fortunes.

Still, the chronic state of oversupply across many of Vedanta’s markets means that severe price reversals could be just around the corner, in my opinion.

Sure, supply problems may leave zinc’s price prospects in better shape than those of many other raw materials. However, the threat of a Chinese economic ‘hard landing’ — along with the prospect of a recovering US dollar — still leaves Vedanta standing on thin ice.

The City expects Vedanta to keep nursing losses through to the close of next year at the earliest. And I wouldn’t like to bet on a solid bottom-line recovery occurring any time soon.

Set to sink?

Likewise, I reckon Premier Oil (LSE: PMO) could also find itself on the defensive sooner rather than later.

The fossil fuels giant leapt last week as the Brent index barged through the $52-per-barrel marker for the first time since November.

But these rises are the result of fevered speculative buying rather than a reflection of sound fundamentals. Indeed, production data from OPEC and Russia continues to be a worry, while there are growing signs that US producers are slowly getting back to work after stoppages earlier this year.

The prospect of a prolonged — and heavy — supply crude market imbalance, not to mention the obvious operational problems associated with oil exploration and production, makes Premier Oil a risk too far in my opinion. Indeed, the City expects the driller to also endure further losses through to the close of 2017, and I wouldn’t bet on a solid bottom-line recovery thereafter.

Royston Wild has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »